Daiichi Sankyo Co Ltd (MEX:4568)
MXN 635.96 0 (0%) Market Cap: 1.07 Til Enterprise Value: 969.66 Bil PE Ratio: 33.70 PB Ratio: 5.15 GF Score: 68/100

Daiichi Sankyo Co Ltd at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 09:30PM GMT
Release Date Price: MXN486.51
Seiji Wakao
JPMorgan Chase & Co, Research Division - VP

Good afternoon, everyone. Welcome to the JPMorgan Healthcare Conference. I'm Seiji Wakao, Japan pharma Analyst, JPMorgan. And it's my pleasure to introduce Manabe-san, CEO of Daiichi Sankyo and welcome him to the conference.

Let me turn it over to Manabe-san. Manabe-san, please go ahead.

Sunao Manabe
Daiichi Sankyo Company, Limited - Group CEO & Executive Chairperson

Thank you, Wakao-san. My name is Sunao Manabe, CEO of Daiichi Sankyo. Hello, colleagues. Thank you for showing interest in Daiichi Sankyo. Also, I'd like to thank JPMorgan for giving me as this opportunity. It was a great experience for me to participate in last year JPMorgan Conference. Then I am very happy to be here again.

Let's go to Page 3. Today, I'll begin by providing a brief overview of Daiichi Sankyo. Then I will present our ADCs focusing on our 5 lead products, and I will take you through our latest R&D strategy. And lastly, I will cover our shareholder returns.

Go to Page 4. Daiichi

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot